Palomar Medical Technologies (PMTI)

Add to Watchlists Create an Alert
13.60 +0.02  +0.15%   NASDAQ May 24, 8:00PM BATS Real time Currency in USD

Palomar Medical Technologies R&D Expense Quarterly:

2.582M for Dec. 31, 2012
View Full Chart

Palomar Medical Technologies R&D Expense Quarterly Chart

    Palomar Medical Technologies Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 2.582M
    Dec. 31, 2012 2.218M
    Sept. 30, 2012 1.872M
    June 30, 2012 2.836M
    March 31, 2012 3.372M
    Dec. 31, 2011 3.845M
    Sept. 30, 2011 4.271M
    June 30, 2011 3.880M
    March 31, 2011 3.648M
    Dec. 31, 2010 4.137M
    Sept. 30, 2010 3.546M
    June 30, 2010 3.589M
    March 31, 2010 4.186M
    Dec. 31, 2009 4.554M
    Sept. 30, 2009 3.305M
    June 30, 2009 3.076M
    March 31, 2009 3.744M
    Dec. 31, 2008 3.540M
    Sept. 30, 2008 4.220M
    June 30, 2008 4.55M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    PMTI R&D Expense Quarterly Benchmarks

    Companies
    Syneron Medical 8.306M
    Cynosure 3.781M
    Cutera 2.121M

    PMTI R&D Expense Quarterly Rankings

    Overall 86th percentile
    1028 of 7600
    Sector 52nd percentile
    307 of 653 in Healthcare
    Industry 50th percentile
    45 of 90 in Medical Devices

    PMTI R&D Expense Quarterly Range, Past 5 Years

    Minimum 1.872M Sep 2012
    Maximum 4.554M Dec 2009
    Average 3.549M